Search Results - Peter End

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cover Image

    Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling by Felix Huth, Hilmar Schiller, Yi Jin, Birk Poller, Carole Schuhler, Wendy Weis, Ralph Woessner, Anton Drollmann, Peter End

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial by Martin Kaul, Peter End, Maciej Cabanski, Carole Schuhler, Annamaria Jakab, Magdalena Kistowska, Arvind Kinhikar, Alessio Maiolica, Angela Sinn, Rainard Fuhr, Bruno Cenni

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: